Influenza vaccination in patients with pulmonary sarcoidosis: efficacy and safety.

Influenza Other Respir Viruses · 2012 · PMC4942082 · PMID 21955954

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Response measures among study groups Serological response to influenza vaccine antigens tended to be more frequent in patients with sarcoidosis than in healthy controls (H1N1: 74% versus 50%; H3N2: 83% versus 62%; B: 65% versus 50%), although the differences did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.